ORAGIN makes stock option grant to a director of the Company with significant industry experience who will take an active role in the development and growth of the Company and its subsidiary Future of Cheese as U.S. expansion plans commence. TORONTO--(BU
Agreement extends current licensing and collaboration agreement to include rapid production of intranasal vaccine candidates against future variants TAMPA, Fla.--(BUSINESS WIRE)--Oragenics, Inc. (NYSE American: OGEN) (“Oragenics” or the “Company”
Vaxess’s new GMP facility in Woburn has successfully produced clinical trial drug product consisting of a proprietary silk fibroin microneedle patch loaded with influenza vaccine antigen The company engaged in a positive Pre-CTA meeting for this
JustBrands named a Director to the US Hemp Roundtable, a non-profit organization behind the drafting and passage of some of the hemp industry’s most significant legislation Flora will send a representative to Washington, D.C. this week to meet with
Presentations include new analyses of AURORA 1 and details on the ENLIGHT-LN registry VICTORIA, British Columbia--(BUSINESS WIRE)--Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (Aurinia or the Company), a biopharmaceutical company committed to delivering t
Canada’s Food & Agri-Tech Engine supports sustainable innovation to advance climate action GUELPH, Ontario--(BUSINESS WIRE)--#PleinsFeuxsurLinnovationDurable--Bioenterprise, Canada’s Food & Agri-Tech Engine, is unveiling its commitment to sup
After a successful pilot program MedX Health and Vitamed Biomedical have entered into a long-term commercial distribution agreement with an immediate commitment to purchase 40 SIAscope units MISSISSAUGA, Ontario--(BUSINESS WIRE)--$MDX #SkinCancer--MedX H
WALTHAM, Mass. & MONTREAL--(BUSINESS WIRE)--Ventus Therapeutics, Inc., a biopharmaceutical company utilizing structural biology and a proprietary computational platform to identify and develop small molecule therapeutics across a broad range of diseases,
DARTMOUTH, Nova Scotia & CAMBRIDGE, Mass.--(BUSINESS WIRE)--IMV Inc. (NASDAQ: IMV; TSX: IMV), a clinical-stage company developing a portfolio of immune-educating therapies based on its novel DPX platform to treat solid and hematologic cancers, today annou
Colombia completes required regulations to allow Colombian cannabis companies, including Flora Growth, to export THC and CBD dried flower globally Flora Growth reaffirms its ability to produce 43.6 tonnes of low-cost THC and CBD production costs of 6
Sign up for one of BAM's newsletter to learn more about bioscience, happenings in Manitoba's bioeconomy, industry conferences, and BAM training events.